Cargando…
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
Authorization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions a...
Autores principales: | Weitzman, Elissa R, Sherman, Amy C, Levy, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129203/ https://www.ncbi.nlm.nih.gov/pubmed/35579499 http://dx.doi.org/10.1093/cid/ciac343 |
Ejemplares similares
-
Precision Vaccines: Lessons Learned From the Coronavirus Pandemic( )
por: Angelidou, Asimenia, et al.
Publicado: (2022) -
A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations( )
por: Dowling, David J, et al.
Publicado: (2022) -
Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making( )
por: Weitzman, Elissa R, et al.
Publicado: (2022) -
Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection( )
por: Odumade, Oludare A, et al.
Publicado: (2022) -
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Africa: Current Considerations and Future Projections( )
por: Idoko, Olubukola T, et al.
Publicado: (2022)